Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study

No liquid biomarkers are approved in metastatic renal cell carcinoma (mRCC) despite the need to predict and monitor response noninvasively to tailor treatment choices. Urine and plasma free glycosaminoglycan profiles (GAGomes) are promising metabolic biomarkers in mRCC. The objective of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatto, Francesco, Bratulic, Sinisa, Jonasch, Eric, Limeta, Angelo, Maccari, Francesca, Galeotti, Fabio, Volpi, Nicola, Lundstam, Sven, Nielsen, Jens, Stierner, Ulrika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309541/
https://www.ncbi.nlm.nih.gov/pubmed/36848607
http://dx.doi.org/10.1200/PO.22.00361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309541/
https://www.ncbi.nlm.nih.gov/pubmed/36848607
http://dx.doi.org/10.1200/PO.22.00361

Ejemplares similares